In vivo blunt-end cloning through CRISPR/Cas9-facilitated non-homologous end-joining

Nucleic Acids Research

Volumn 44, Issue 8, 2016, Pages

  Geisinger, Jonathan M ^a   Turan, Sören ^a   Hernandez, Sophia ^a   Spector, Laura P ^a   Calos, Michele P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAS9 PROTEIN; CRISPR ASSOCIATED PROTEIN; UNCLASSIFIED DRUG; GUIDE RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CRISPR CAS SYSTEM; DNA END JOINING REPAIR; DNA SEQUENCE; DOUBLE STRANDED DNA BREAK; GENE CASSETTE; GENE INSERTION; GENE LOCUS; HUMAN; HUMAN CELL; IN VIVO BLUNT END CLONING; MOLECULAR CLONING; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN; SEQUENCE HOMOLOGY; ANIMAL; CELL LINE; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; GENETIC ENGINEERING; GENETICS; GENOME; HEK293 CELL LINE; PROCEDURES; RNA EDITING;

ANIMALS; CELL LINE; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; CRISPR-ASSOCIATED PROTEINS; CRISPR-CAS SYSTEMS; DNA BREAKS, DOUBLE-STRANDED; DNA END-JOINING REPAIR; GENETIC ENGINEERING; GENOME; HEK293 CELLS; HUMANS; MICE; RNA EDITING; RNA, GUIDE;

EID: 84966344968     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkv1542     Document Type: Article

References (78)

1. Jinek,M., East,A., Cheng,A., Lin,S., Ma,E. and Doudna,J. (2013) RNA-programmed genome editing in human cells. eLife, 2, e00471.
2. Barrangou,R., Fremaux,C., Deveau,H., Richards,M., Boyaval,P., Moineau,S., Romero,D.A. and Horvath,P. (2007) CRISPR provides acquired resistance against viruses in prokaryotes. Science, 315, 1709-1712.
3. Jinek,M., Chylinski,K., Fonfara,I., Hauer,M., Doudna,J.A. and Charpentier,E. (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science, 337, 816-821.
4. Sternberg,S.H., Redding,S., Jinek,M., Greene,E.C. and Doudna,J.A. (2014) DNA interrogation by the CRISPR RNA-guided endonuclease Cas9. Nature, 507, 62-67.
5. Mali,P., Yang,L., Esvelt,K.M., Aach,J., Guell,M., DiCarlo,J.E., Norville,J.E. and Church,G.M. (2013) RNA-guided human genome engineering via Cas9. Science, 339, 823-826.
6. Cong,L., Ran,F.A., Cox,D., Lin,S., Barretto,R., Habib,N., Hsu,P.D., Wu,X., Jiang,W., Marraffini,L.A. et al. (2013) Multiplex genome engineering using CRISPR/Cas systems. Science, 339, 819-823.
7. Friedland,A.E., Tzur,Y.B., Esvelt,K.M., Colaiácovo,M.P., Church,G.M. and Calarco,J.A. (2013) Heritable genome editing in C. elegans via a CRISPR-Cas9 system. Nat. Methods, 10, 741-743.
8. Kim,H., Ishidate,T., Ghanta,K.S., Seth,M., Conte,D., Shirayama,M. and Mello,C.C. (2014) A co-CRISPR strategy for efficient genome editing in Caenorhabditis elegans. Genetics, 197, 1069-1080.
9. Gratz,S.J., Ukken,F.P., Rubinstein,C.D., Thiede,G., Donohue,L.K., Cummings,A.M. and O'Connor-Giles,K.M. (2014) Highly specific and efficient CRISPR/Cas9-catalyzed homology-directed repair in Drosophila. Genetics, 196, 961-971.
10. Zhang,X., Koolhaas,W.H. and Schnorrer,F. (2014) A versatile two-step CRISPR- and RMCE-based strategy for efficient genome engineering in Drosophila. G3 (Bethesda), 4, 2409-2418.
11. DiCarlo,J.E., Norville,J.E., Mali,P., Rios,X., Aach,J. and Church,G.M. (2013) Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems. Nucleic Acids Res., 41, 4336-4343.
12. Harel,I., Benayoun,B.A., Machado,B., Singh,P.P., Hu,C.-K., Pech,M.F., Valenzano,D.R., Zhang,E., Sharp,S.C., Artandi,S.E. et al. (2015) A platform for rapid exploration of aging and diseases in a naturally short-lived vertebrate. Cell, 160, 1013-1026.
13. Xue,W., Chen,S., Yin,H., Tammela,T., Papagiannakopoulos,T., Joshi,N.S., Cai,W., Yang,G., Bronson,R., Crowley,D.G. et al. (2014) CRISPR-mediated direct mutation of cancer genes in the mouse liver. Nature, 514, 380-384.
14. Heckl,D., Kowalczyk,M.S., Yudovich,D., Belizaire,R., Puram,R.V., McConkey,M.E., Thielke,A., Aster,J.C., Regev,A. and Ebert,B.L. (2014) Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing. Nat. Biotechnol., 32, 941-946.
15. Platt,R.J., Chen,S., Zhou,Y., Yim,M.J., Swiech,L., Kempton,H.R., Dahlman,J.E., Parnas,O., Eisenhaure,T.M., Jovanovic,M. et al. (2014) CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell, 159, 440-455.
16. Hu,W., Kaminski,R., Yang,F., Zhang,Y., Cosentino,L., Li,F., Luo,B., Alvarez-Carbonell,D., Garcia-Mesa,Y., Karn,J. et al. (2014) RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection. Proc. Natl. Acad. Sci. U.S.A., 111, 11461-11466.
17. Wang,J. and Quake,S.R. (2014) RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection. Proc. Natl. Acad. Sci. U.S.A., 111, 13157-13162.
18. Ousterout,D.G., Kabadi,A.M., Thakore,P.I., Majoros,W.H., Reddy,T.E. and Gersbach,C.A. (2015) Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy. Nat. Commun., 6, 6244.
19. Van Heemst,D., Brugmans,L., Verkaik,N.S. and van Gent,D.C. (2004) End-joining of blunt DNA double-strand breaks in mammalian fibroblasts is precise and requires DNA-PK and XRCC4. DNA Repair (Amst.), 3, 43-50.
20. Ghezraoui,H., Piganeau,M., Renouf,B., Renaud,J.-B., Sallmyr,A., Ruis,B., Oh,S., Tomkinson,A.E., Hendrickson,E.A., Giovannangeli,C. et al. (2014) Chromosomal translocations in human cells are generated by canonical nonhomologous end-joining. Mol. Cell, 55, 829-842.
21. Auer,T.O., Duroure,K., DE Cian,A., Concordet,J.-P. and Del Bene,F. (2014) Highly efficient CRISPR/Cas9-mediated knock-in in zebrafish by homology-independent DNA repair. Genome Res., 24, 142-153.
22. Bachu,R., Bergareche,I. and Chasin,L.A. (2015) CRISPR-Cas targeted plasmid integration into mammalian cells via non-homologous end joining: targeted plasmid insertion in mammalian cells. Biotechnol. Bioeng., 10.1002/bit.25629.
23. Banaszynski,L.A., Chen,L., Maynard-Smith,L.A., Ooi,A.G.L. and Wandless,T.J. (2006) A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules. Cell, 126, 995-1004.
24. Zhang,Y., Vanoli,F., LaRocque,J.R., Krawczyk,P.M. and Jasin,M. (2014) Biallelic targeting of expressed genes in mouse embryonic stem cells using the Cas9 system. Methods, 69, 171-178.
25. Dean,F.B., Hosono,S., Fang,L., Wu,X., Faruqi,A.F., Bray-Ward,P., Sun,Z., Zong,Q., Du,Y., Du,J. et al. (2002) Comprehensive human genome amplification using multiple displacement amplification. Proc. Natl. Acad. Sci. U.S.A., 99, 5261-5266.
26. Canver,M.C., Bauer,D.E., Dass,A., Yien,Y.Y., Chung,J., Masuda,T., Maeda,T., Paw,B.H. and Orkin,S.H. (2014) Characterization of genomic deletion efficiency mediated by clustered regularly interspaced palindromic repeats (CRISPR)/Cas9) nuclease system in mammalian cells. J. Biol. Chem., 289, 21312-21324.
27. Zhou,J., Wang,J., Shen,B., Chen,L., Su,Y., Yang,J., Zhang,W., Tian,X. and Huang,X. (2014) Dual sgRNAs facilitate CRISPR/Cas9-mediated mouse genome targeting. FEBS J., 281, 1717-1725.
28. Zhu,F., Gamboa,M., Farruggio,A.P., Hippenmeyer,S., Tasic,B., Schule,B., Chen-Tsai,Y. and Calos,M.P. (2014) DICE, an efficient system for iterative genomic editing in human pluripotent stem cells. Nucleic Acids Res., 42, e34-e34.
29. Lam,A.J., St-Pierre,F., Gong,Y., Marshall,J.D., Cranfill,P.J., Baird,M.A., McKeown,M.R., Wiedenmann,J., Davidson,M.W., Schnitzer,M.J. et al. (2012) Improving FRET dynamic range with bright green and red fluorescent proteins. Nat. Methods, 9, 1005-1012.
30. Tsutsui,H., Karasawa,S., Okamura,Y. and Miyawaki,A. (2008) Improving membrane voltage measurements using FRET with new fluorescent proteins. Nat. Methods, 5, 683-685.
31. Chu,J., Haynes,R.D., Corbel,S.Y., Li,P., González-González,E., Burg,J.S., Ataie,N.J., Lam,A.J., Cranfill,P.J., Baird,M.A. et al. (2014) Non-invasive intravital imaging of cellular differentiation with a bright red-excitable fluorescent protein. Nat. Methods, 11, 572-578.
32. Rizzo,M.A., Springer,G.H., Granada,B. and Piston,D.W. (2004) An improved cyan fluorescent protein variant useful for FRET. Nat. Biotechnol., 22, 445-449.
33. Tasic,B., Hippenmeyer,S., Wang,C., Gamboa,M., Zong,H., Chen-Tsai,Y. and Luo,L. (2011) Site-specific integrase-mediated transgenesis in mice via pronuclear injection. Proc. Natl. Acad. Sci. U.S.A., 108, 7902-7907.
34. Pruett-Miller,S.M., Reading,D.W., Porter,S.N. and Porteus,M.H. (2009) Attenuation of zinc finger nuclease toxicity by small-molecule regulation of protein levels. PLoS Genet., 5, e1000376.
35. Maynard-Smith,L.A., Chen,L.-C., Banaszynski,L.A., Ooi,A.G.L. and Wandless,T.J. (2007) A directed approach for engineering conditional protein stability using biologically silent small molecules. J. Biol. Chem., 282, 24866-24872.
36. Zheng,Q., Cai,X., Tan,M.H., Schaffert,S., Arnold,C.P., Gong,X., Chen,C.-Z. and Huang,S. (2014) Precise gene deletion and replacement using the CRISPR/Cas9 system in human cells. Biotechniques, 57, 115-124.
37. Li,K., Wang,G., Andersen,T., Zhou,P. and Pu,W.T. (2014) Optimization of genome engineering approaches with the CRISPR/Cas9 system. PLoS ONE, 9, e105779.
38. Tsai,S.Q., Zheng,Z., Nguyen,N.T., Liebers,M., Topkar,V.V., Thapar,V., Wyvekens,N., Khayter,C., Iafrate,A.J., Le,L.P. et al. (2014) GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat. Biotechnol., 33, 187-197.
39. Nakade,S., Tsubota,T., Sakane,Y., Kume,S., Sakamoto,N., Obara,M., Daimon,T., Sezutsu,H., Yamamoto,T., Sakuma,T. et al. (2014) Microhomology-mediated end-joining-dependent integration of donor DNA in cells and animals using TALENs and CRISPR/Cas9. Nat. Commun., 5, 5560.
40. Cristea,S., Freyvert,Y., Santiago,Y., Holmes,M.C., Urnov,F.D., Gregory,P.D. and Cost,G.J. (2013) In vivo cleavage of transgene donors promotes nuclease-mediated targeted integration. Biotechnol. Bioeng., 110, 871-880.
41. Ran,F.A., Hsu,P.D., Lin,C.-Y., Gootenberg,J.S., Konermann,S., Trevino,A.E., Scott,D.A., Inoue,A., Matoba,S., Zhang,Y. et al. (2013) Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell, 154, 1380-1389.
42. Maresca,M., Lin,V.G., Guo,N. and Yang,Y. (2013) Obligate ligation-gated recombination (ObLiGaRe): custom-designed nuclease-mediated targeted integration through nonhomologous end joining. Genome Res., 23, 539-546.
43. Bottcher,R., Hollmann,M., Merk,K., Nitschko,V., Obermaier,C., Philippou-Massier,J., Wieland,I., Gaul,U. and Forstemann,K. (2014) Efficient chromosomal gene modification with CRISPR/cas9 and PCR-based homologous recombination donors in cultured Drosophila cells. Nucleic Acids Res., 42, e89-e89.
44. Lin,S., Staahl,B.T., Alla,R.K. and Doudna,J.A. (2014) Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery. eLife, 3, e04766.
45. Singh,P., Schimenti,J.C. and Bolcun-Filas,E. (2015) A mouse geneticist's practical huide to CRISPR applications. Genetics, 199, 1-15.
46. Chu,V.T., Weber,T., Wefers,B., Wurst,W., Sander,S., Rajewsky,K. and Kühn,R. (2015) Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells. Nat. Biotechnol., 33, 543-548.
47. Maruyama,T., Dougan,S.K., Truttmann,M.C., Bilate,A.M., Ingram,J.R. and Ploegh,H.L. (2015) Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining. Nat. Biotechnol., 33, 538-542.
48. Beumer,K.J., Trautman,J.K., Bozas,A., Liu,J.-L., Rutter,J., Gall,J.G. and Carroll,D. (2008) Efficient gene targeting in Drosophila by direct embryo injection with zinc-finger nucleases. Proc. Natl. Acad. Sci. U.S.A., 105, 19821-19826.
49. Bozas,A., Beumer,K.J., Trautman,J.K. and Carroll,D. (2009) Genetic analysis of zinc-finger nuclease-induced gene targeting in Drosophila. Genetics, 182, 641-651.
50. Swiech,L., Heidenreich,M., Banerjee,A., Habib,N., Li,Y., Trombetta,J., Sur,M. and Zhang,F. (2014) In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9. Nat. Biotechnol., 33, 102-106.
51. Flach,J., Bakker,S.T., Mohrin,M., Conroy,P.C., Pietras,E.M., Reynaud,D., Alvarez,S., Diolaiti,M.E., Ugarte,F., Forsberg,E.C. et al. (2014) Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells. Nature, 512, 198-202.
52. Beerman,I., Seita,J., Inlay,M.A., Weissman,I.L. and Rossi,D.J. (2014) Quiescent hematopoietic stem cells accumulate DNA damage during aging that Is repaired upon entry into cell cycle. Cell Stem Cell, 15, 37-50.
53. Vahidi Ferdousi,L., Rocheteau,P., Chayot,R., Montagne,B., Chaker,Z., Flamant,P., Tajbakhsh,S. and Ricchetti,M. (2014) More efficient repair of DNA double-strand breaks in skeletal muscle stem cells compared to their committed progeny. Stem Cell Res., 13, 492-507.
54. Findlay,G.M., Boyle,E.A., Hause,R.J., Klein,J.C. and Shendure,J. (2014) Saturation editing of genomic regions by multiplex homology-directed repair. Nature, 513, 120-123.
55. Hsu,P.D., Scott,D.A., Weinstein,J.A., Ran,F.A., Konermann,S., Agarwala,V., Li,Y., Fine,E.J., Wu,X., Shalem,O. et al. (2013) DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol., 31, 827-832.
56. Zhu,Z., González,F. and Huangfu,D. (2014) The iCRISPR platform for rapid genome editing in human pluripotent stem cells. In: Methods in Enzymology. Elsevier, Vol. 546, pp. 215-250.
57. Wright,A.V., Sternberg,S.H., Taylor,D.W., Staahl,B.T., Bardales,J.A., Kornfeld,J.E. and Doudna,J.A. (2015) Rational design of a split-Cas9 enzyme complex. Proc. Natl. Acad. Sci. U.S.A., 112, 2984-2989.
58. Zetsche,B., Volz,S.E. and Zhang,F. (2015) A split-Cas9 architecture for inducible genome editing and transcription modulation. Nat. Biotechnol., 33, 139-142.
59. Banaszynski,L.A., Sellmyer,M.A., Contag,C.H., Wandless,T.J. and Thorne,S.H. (2008) Chemical control of protein stability and function in living mice. Nat. Med., 14, 1123-1127.
60. Davis,K.M., Pattanayak,V., Thompson,D.B., Zuris,J.A. and Liu,D.R. (2015) Small molecule-triggered Cas9 protein with improved genome-editing specificity. Nat. Chem. Biol., 11, 316-318.
61. Fu,Y., Foden,J.A., Khayter,C., Maeder,M.L., Reyon,D., Joung,J.K. and Sander,J.D. (2013) High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat. Biotechnol., 31, 822-826.
62. Pattanayak,V., Lin,S., Guilinger,J.P., Ma,E., Doudna,J.A. and Liu,D.R. (2013) High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat. Biotechnol., 31, 839-843.
63. Cho,S.W., Kim,S., Kim,Y., Kweon,J., Kim,H.S., Bae,S. and Kim,J.-S. (2014) Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases. Genome Res., 24, 132-141.
64. Lin,Y., Cradick,T.J., Brown,M.T., Deshmukh,H., Ranjan,P., Sarode,N., Wile,B.M., Vertino,P.M., Stewart,F.J. and Bao,G. (2014) CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences. Nucleic Acids Res., 42, 7473-7485.
65. Hua Fu,B.X., Hansen,L.L., Artiles,K.L., Nonet,M.L. and Fire,A.Z. (2014) Landscape of target:guide homology effects on Cas9-mediated cleavage. Nucleic Acids Res., 42, 13778-13787.
66. Wu,X., Scott,D.A., Kriz,A.J., Chiu,A.C., Hsu,P.D., Dadon,D.B., Cheng,A.W., Trevino,A.E., Konermann,S., Chen,S. et al. (2014) Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells. Nat. Biotechnol., 32, 670-676.
67. Kuscu,C., Arslan,S., Singh,R., Thorpe,J. and Adli,M. (2014) Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease. Nat. Biotechnol., 32, 677-683.
68. Cencic,R., Miura,H., Malina,A., Robert,F., Ethier,S., Schmeing,T.M., Dostie,J. and Pelletier,J. (2014) Protospacer adjacent motif (PAM)-distal sequences engage CRISPR Cas9 DNA target cleavage. PLoS ONE, 9, e109213.
69. Veres,A., Gosis,B.S., Ding,Q., Collins,R., Ragavendran,A., Brand,H., Erdin,S., Cowan,C.A., Talkowski,M.E. and Musunuru,K. (2014) Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by hole-genome sequencing. Cell Stem Cell, 15, 27-30.
70. Xie,F., Ye,L., Chang,J.C., Beyer,A.I., Wang,J., Muench,M.O. and Kan,Y.W. (2014) Seamless gene correction of β-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 and piggyBac. Genome Res., 24, 1526-1533.
71. Yang,L., Grishin,D., Wang,G., Aach,J., Zhang,C.-Z., Chari,R., Homsy,J., Cai,X., Zhao,Y., Fan,J.-B. et al. (2014) Targeted and genome-wide sequencing reveal single nucleotide variations impacting specificity of Cas9 in human stem cells. Nat. Commun., 5, 5507.
72. Mandal,P.K., Ferreira,L.M.R., Collins,R., Meissner,T.B., Boutwell,C.L., Friesen,M., Vrbanac,V., Garrison,B.S., Stortchevoi,A., Bryder,D. et al. (2014) Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9. Cell Stem Cell, 15, 643-652.
73. Iyer,V., Shen,B., Zhang,W., Hodgkins,A., Keane,T., Huang,X. and Skarnes,W.C. (2015) Off-target mutations are rare in Cas9-modified mice. Nat. Methods, 12, 479-479.
74. Wang,X., Wang,Y., Wu,X., Wang,J., Wang,Y., Qiu,Z., Chang,T., Huang,H., Lin,R.-J. and Yee,J.-K. (2015) Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors. Nat. Biotechnol., 33, 175-178.
75. Frock,R.L., Hu,J., Meyers,R.M., Ho,Y.-J., Kii,E. and Alt,F.W. (2014) Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases. Nat. Biotechnol., 33, 179-186.
76. Barzel,A., Paulk,N.K., Shi,Y., Huang,Y., Chu,K., Zhang,F., Valdmanis,P.N., Spector,L.P., Porteus,M.H., Gaensler,K.M. et al. (2014) Promoterless gene targeting without nucleases ameliorates haemophilia B in mice. Nature, 517, 360-364.
77. Byrne,S.M., Ortiz,L., Mali,P., Aach,J. and Church,G.M. (2015) Multi-kilobase homozygous targeted gene replacement in human induced pluripotent stem cells. Nucleic Acids Res., 43, e21-e21.
78. Bétermier,M., Bertrand,P. and Lopez,B.S. (2014) Is non-homologous end-joining really an inherently error-prone process? PLoS Genet., 10, e1004086.